{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:15:16Z","timestamp":1783318516134,"version":"3.54.6"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acral melanoma (AM) is a non-ultraviolet (non-UV)-derived subtype of cutaneous melanoma that is associated with worse survival outcomes compared to UV-driven melanomas. AM tumors exhibit distinct molecular characteristics and poor responses to immune checkpoint blockade. Hitherto, the role of transposable elements (TEs), particularly human endogenous retroviruses (HERVs), in AM progression remains incompletely characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We quantified locus-specific TE expression from RNA sequencing (RNA-seq) of 36 AM samples from 33 patients and integrated the results with clinical outcomes, a pathologist-reviewed purity covariate, and immune cell deconvolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A three-locus HERV signature, composed of\n                      <jats:italic>ERV316A3_6p25.1d, HERVH_6q21a<\/jats:italic>\n                      , and\n                      <jats:italic>ERVLE_9q21.32c<\/jats:italic>\n                      , stratified AM tumors by overall survival with a leave-one-patient-out C-index of 0.778 (bootstrap 95% confidence interval [CI]: 0.614\u20130.914, permutation\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.015) and a Kaplan\u2013Meier log-rank of\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.003 across risk tertiles. In a multivariable Cox model adjusted for primary site, tumor cellularity pathology, sex, ulceration, and Breslow depth, with patient-clustered robust standard errors, the signature remained strongly prognostic (HR: 2.19 per 1-standard deviation [s.d.] increase in risk score, 95% CI: 1.38\u20133.47,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.001). High-risk tumors were natural killer (NK)-cell-depleted (Spearman\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u202f=\u202f\u22120.58, false discovery rate [FDR]\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.004) and showed coordinated elevation of\n                      <jats:italic>LIN28A<\/jats:italic>\n                      and\n                      <jats:italic>HMGA2<\/jats:italic>\n                      (\u03c1\u202f=\u202f+0.55 and +0.45), consistent with reactivation of the\n                      <jats:italic>LIN28A\/let-7\/HMGA2<\/jats:italic>\n                      oncofetal axis rather than a full pluripotency program. High-risk tumors were also associated with reduced odds ratio of response to immune checkpoint inhibitor (ICI) therapy (OR: 0.20 per 1-s.d. increase,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.075), whereas reported mutation burden was not (OR: 1.02,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.80), consistent with the unexplained low-TMB checkpoint responders previously reported in this cohort. A single locus,\n                      <jats:italic>HML6_20p11.21<\/jats:italic>\n                      , retained a full 9.14\u202fkb proviral structure and a 333-aa open reading frame (ORF) with intact integrase, protease, and gag motifs. Peptide-human leukocyte antigen (HLA) binding predictions identified strong HML6-derived binders for every HLA class I allele in the typed cohort, and at least one strong binder in all 25 typed patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings reframe AM as a transcriptomically stratifiable disease, define a locus-specific HERV signature of aggressive, checkpoint-refractory AM, and nominate a structurally intact, pan-HLA-presentable HERV-K antigen candidate for further evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1834744","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:37:55Z","timestamp":1783316275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Locus-specific HERV expression identifies an aggressive, NK-depleted, checkpoint-refractory acral melanoma phenotype"],"prefix":"10.3389","volume":"13","author":[{"given":"Jez L.","family":"Marston","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Weill Cornell Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyi","family":"Fei","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Weill Cornell Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Reyes-Gopar","sequence":"additional","affiliation":[{"name":"Northwell Health, Institute of Translational Research, Feinstein Institutes for Medical Research","place":["Manhasset, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Bendall","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Weill Cornell Medicine","place":["New York, NY, United States"]},{"name":"Department of Biostatistics and Bioinformatics, Computational Biology Institute, Milken Institute School of Public Health, George Washington University","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Nixon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Weill Cornell Medicine","place":["New York, NY, United States"]},{"name":"Northwell Health, Institute of Translational Research, Feinstein Institutes for Medical Research","place":["Manhasset, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"100947","DOI":"10.1016\/j.neo.2023.100947","article-title":"Acral melanoma: new insights into the immune and genomic landscape","volume":"46","author":"Carvalho","year":"2023","journal-title":"Neoplasia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1038\/s41467-024-50233-z","article-title":"The genetic evolution of acral melanoma","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1038\/s41467-022-31488-w","article-title":"Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure","volume":"13","author":"Vicente","year":"2022","journal-title":"Nat Commun"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrg.2016.139","article-title":"Regulatory activities of transposable elements: from conflicts to benefits","volume":"18","author":"Chuong","year":"2017","journal-title":"Nat Rev Genet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12864-023-09909-x","article-title":"Ribosomal profiling of human endogenous retroviruses in healthy tissues","volume":"25","author":"Dopkins","year":"2024","journal-title":"BMC Genomics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-genet-040620-022145","article-title":"A field guide to eukaryotic transposable elements","volume":"54","author":"Wells","year":"2020","journal-title":"Annu Rev Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41580-022-00457-y","article-title":"Roles of transposable elements in the regulation of mammalian transcription","volume":"23","author":"Fueyo","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1016\/j.molcel.2022.09.011","article-title":"A field guide to endogenous retrovirus regulatory networks","volume":"82","author":"Dopkins","year":"2022","journal-title":"Mol Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e70399","DOI":"10.1371\/journal.pone.0070399","article-title":"The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expression","volume":"8","author":"Morozov","year":"2013","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"708404","DOI":"10.3389\/fmicb.2021.708404","article-title":"An ancestral retrovirus envelope protein regulates persistent gammaherpesvirus lifecycles","volume":"12","author":"Frey","year":"2021","journal-title":"Front Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"15573","DOI":"10.1128\/JVI.79.24.15573-15577.2005","article-title":"Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses","volume":"79","author":"Dewannieux","year":"2005","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1073\/pnas.0707873105","article-title":"Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins","volume":"104","author":"Mangeney","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1172\/JCI121476","article-title":"Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma","volume":"128","author":"Smith","year":"2018","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jitc-2024-009147","article-title":"Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus","volume":"12","author":"Barisic","year":"2024","journal-title":"J Immunother Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/cancers15174340","article-title":"The regulation and immune signature of retrotransposons in cancer","volume":"15","author":"Alkailani","year":"2023","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1016\/j.cell.2024.11.016","article-title":"Regulation of human interferon signaling by transposon exonization","volume":"187","author":"Pasquesi","year":"2024","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1101\/2024.08.09.606346","article-title":"Adaptive immunity to retroelements promotes barrier integrity","volume-title":"bioRxiv","author":"Wells","year":"2024"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1016\/j.cell.2021.05.020","article-title":"Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota","volume":"184","author":"Lima-Junior","year":"2021","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1006451","DOI":"10.1371\/journal.ppat.1006451","article-title":"A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion","volume":"13","author":"Lemaitre","year":"2017","journal-title":"PLoS Pathog"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/CMR.0b013e32833c1b5d","article-title":"Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation","volume":"20","author":"Reiche","year":"2010","journal-title":"Melanoma Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3109\/07357907.2010.512604","article-title":"Expression of HERV-K correlates with status of MEK-ERK and p16INK4A-CDK4 pathways in melanoma cells","volume":"28","author":"Li","year":"2010","journal-title":"Cancer Investig"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1755-148X.2011.00860.x","article-title":"Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma","volume":"24","author":"Schanab","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/bjs.1800780110","article-title":"Peptic ulcer surgery during the H2-receptor antagonist era: a population-based epidemiological study of ulcer surgery in Helsinki from 1972 to 1987","volume":"78","author":"Paimela","year":"1991","journal-title":"Br J Surg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/v12111303","article-title":"Human endogenous retrovirus K rec forms a regulatory loop with MITF that opposes the progression of melanoma to an invasive stage","volume":"12","author":"Singh","year":"2020","journal-title":"Viruses"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"946296","DOI":"10.3389\/fmicb.2022.946296","article-title":"Transcriptional and reverse transcriptional regulation of host genes by human endogenous retroviruses in cancers","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.7150\/jca.50277","article-title":"Decoding immune heterogeneity of melanoma and identifying immune-prognostic hub genes","volume":"12","author":"Zhang","year":"2021","journal-title":"J Cancer"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3389\/fmicb.2020.01690","article-title":"Human endogenous retrovirus K (HML-2) in health and disease","volume":"11","author":"Xue","year":"2020","journal-title":"Front Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jid.2019.11.021","article-title":"Cutaneous T-cell lymphoma (CTCL) cell line-derived extracellular vesicles contain HERV-W-encoded Fusogenic Syncytin-1","volume":"140","author":"Laukkanen","year":"2020","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2133.2005.06555.x","article-title":"A new endogenous retroviral sequence is expressed in skin of patients with psoriasis","volume":"153","author":"Moles","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12967-014-0256-4","article-title":"Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis","volume":"12","author":"Gupta","year":"2014","journal-title":"J Transl Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1073\/pnas.2115999119","article-title":"LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint","volume":"119","author":"McKerrow","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1038\/s41598-024-54113-w","article-title":"Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level","volume":"14","author":"Perkio","year":"2024","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.18632\/oncotarget.1403","article-title":"A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines","volume":"4","author":"Sciamanna","year":"2013","journal-title":"Oncotarget"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/2159-8290.CD-21-1117","article-title":"Reverse transcriptase inhibition disrupts repeat element life cycle in colorectal cancer","volume":"12","author":"Rajurkar","year":"2022","journal-title":"Cancer Discov"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e1006453","DOI":"10.1371\/journal.pcbi.1006453","article-title":"Telescope: characterization of the retrotranscriptome by accurate estimation of transposable element expression","volume":"15","author":"Bendall","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2147\/CCID.S404381","article-title":"Single-cell RNA sequencing reveals cellular heterogeneity in an Acral Amelanotic melanoma after immunotherapy treatment","volume":"16","author":"Zhuang","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.20517\/jtgg.2018.25","article-title":"Clinical and therapeutic implications of melanoma genomics","volume":"2","author":"Shaughnessy","year":"2018","journal-title":"J Trans Genet Genom"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e147172","DOI":"10.1172\/jci.insight.147172","article-title":"Specific human endogenous retroviruses predict metastatic potential in uveal melanoma","volume":"7","author":"Bendall","year":"2022","journal-title":"JCI Insight"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00239-004-2656-1","article-title":"Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations","volume":"59","author":"Macfarlane","year":"2004","journal-title":"J Mol Evol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.1603569113","article-title":"HERV-K HML-2 diversity among humans","volume":"113","author":"Lenz","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13100-015-0035-7","article-title":"HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues","volume":"6","author":"Schmitt","year":"2015","journal-title":"Mob DNA"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/1078-0432.CCR-14-0388","article-title":"Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells","volume":"21","author":"Rycaj","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1708501","DOI":"10.3389\/fonc.2026.1708501","article-title":"Human endogenous retrovirus profiling reveals heterogeneous expression in cutaneous melanoma","volume":"16","author":"Fei","year":"2026","journal-title":"Front Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1834744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:37:56Z","timestamp":1783316276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1834744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":45,"alternative-id":["10.3389\/fmed.2026.1834744"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1834744","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1834744"}}